20210517-lab meeting_麗宇
-
00:00
1.
index 1
-
00:29
2.
Introduction
-
00:30
3.
Breast cancer (BC)
-
00:44
4.
Subtypes of breast cancer:
-
00:49
5.
Breast cancer (BC)
-
01:15
6.
** after 20210427.pptx
-
01:26
7.
Subtypes of breast cancer:
-
02:10
8.
Treatments of breast cancer
-
03:01
9.
Chemotherapy of triple-negative breast cancer
-
03:51
10.
Long non-coding RNA (lnc RNA)
-
04:48
11.
Myc
-
05:28
12.
Aim of this study
-
05:44
13.
Slide 10
-
05:45
14.
Identification of lncRNAs differentially expressed in breast cancer
-
06:50
15.
Slide 10
-
06:50
16.
Aim of this study
-
06:50
17.
Myc
-
06:51
18.
Long non-coding RNA (lnc RNA)
-
06:53
19.
Chemotherapy of triple-negative breast cancer
-
06:57
20.
Long non-coding RNA (lnc RNA)
-
06:58
21.
Myc
-
06:59
22.
Aim of this study
-
06:59
23.
Slide 10
-
06:59
24.
Identification of lncRNAs differentially expressed in breast cancer
-
08:11
25.
Slide 12
-
08:59
26.
Slide 13
-
09:01
27.
Slide 12
-
09:38
28.
Slide 13
-
09:56
29.
Slide 14
-
11:18
30.
Linc00839 knockdown suppressed cell proliferation and increased sensitivity to paclitaxel in vitro.
-
12:48
31.
Slide 16
-
15:50
32.
Slide 17
-
15:55
33.
Slide 16
-
15:57
34.
Slide 17
-
17:44
35.
Linc00839 knockdown inhibited tumor proliferation in vivo.
-
20:41
36.
Myc activates Linc00839 transcription and regulates its expression level.
-
21:41
37.
Slide 20
-
21:43
38.
Myc activates Linc00839 transcription and regulates its expression level.
-
21:59
39.
Slide 20
-
25:42
40.
Linc00839 regulates Lin28B and Myc mRNA and protein expression.
-
31:27
41.
Slide 22
-
34:39
42.
Slide 23
-
34:40
43.
Slide 22
-
35:29
44.
Slide 23
-
38:30
45.
Linc00839 promotes cell invasion and proliferation via PI3K/AKT Signaling Pathways
-
40:25
46.
Slide 25
-
40:28
47.
Linc00839 promotes cell invasion and proliferation via PI3K/AKT Signaling Pathways
-
41:31
48.
Slide 25
-
43:09
49.
Slide 26
-
45:57
50.
Slide 27
-
45:57
51.
Comment
-
46:47
52.
** after 20210427.pptx
-
58:13
53.
Slide 17
-
00:00
1.
index 1
-
00:29
2.
Introduction
-
00:30
3.
Breast cancer (BC)
-
00:44
4.
Subtypes of breast cancer:
-
00:49
5.
Breast cancer (BC)
-
01:15
6.
** after 20210427.pptx
-
01:26
7.
Subtypes of breast cancer:
-
02:10
8.
Treatments of breast cancer
-
03:01
9.
Chemotherapy of triple-negative breast cancer
-
03:51
10.
Long non-coding RNA (lnc RNA)
-
04:48
11.
Myc
-
05:28
12.
Aim of this study
-
05:44
13.
Slide 10
-
05:45
14.
Identification of lncRNAs differentially expressed in breast cancer
-
06:50
15.
Slide 10
-
06:50
16.
Aim of this study
-
06:50
17.
Myc
-
06:51
18.
Long non-coding RNA (lnc RNA)
-
06:53
19.
Chemotherapy of triple-negative breast cancer
-
06:57
20.
Long non-coding RNA (lnc RNA)
-
06:58
21.
Myc
-
06:59
22.
Aim of this study
-
06:59
23.
Slide 10
-
06:59
24.
Identification of lncRNAs differentially expressed in breast cancer
-
08:11
25.
Slide 12
-
08:59
26.
Slide 13
-
09:01
27.
Slide 12
-
09:38
28.
Slide 13
-
09:56
29.
Slide 14
-
11:18
30.
Linc00839 knockdown suppressed cell proliferation and increased sensitivity to paclitaxel in vitro.
-
12:48
31.
Slide 16
-
15:50
32.
Slide 17
-
15:55
33.
Slide 16
-
15:57
34.
Slide 17
-
17:44
35.
Linc00839 knockdown inhibited tumor proliferation in vivo.
-
20:41
36.
Myc activates Linc00839 transcription and regulates its expression level.
-
21:41
37.
Slide 20
-
21:43
38.
Myc activates Linc00839 transcription and regulates its expression level.
-
21:59
39.
Slide 20
-
25:42
40.
Linc00839 regulates Lin28B and Myc mRNA and protein expression.
-
31:27
41.
Slide 22
-
34:39
42.
Slide 23
-
34:40
43.
Slide 22
-
35:29
44.
Slide 23
-
38:30
45.
Linc00839 promotes cell invasion and proliferation via PI3K/AKT Signaling Pathways
-
40:25
46.
Slide 25
-
40:28
47.
Linc00839 promotes cell invasion and proliferation via PI3K/AKT Signaling Pathways
-
41:31
48.
Slide 25
-
43:09
49.
Slide 26
-
45:57
50.
Slide 27
-
45:57
51.
Comment
-
46:47
52.
** after 20210427.pptx
-
58:13
53.
Slide 17
- 位置
-
- 資料夾名稱
- 2021
- 發表人
- 陳逸安
- 單位
- 賴亮全教授
- 建立
- 2021-04-19 10:46:54
- 最近修訂
- 2021-04-19 11:47:40
- 長度
- 58:36